- Home
- Gastroenterology
- Trial Synopsis: Phase 2 Study of Anti‑TL1A Antibody Tulisokibart in Moderately to Severely Active Ulcerative Colitis

2w3 min read
Medical Article
Introduction: Ulcerative colitis (UC) is a chronic inflammatory disorder of the gastrointestinal tract, typically presenting with abdominal pain, diarrhea, and rectal bleeding (1). Although several biologic and small‑molecule therapies are available for patients with moderately to severely active disease, the overall rates of long‑term remission re

Trial Synopsis: Phase 2 Study of Anti‑TL1A Antibody Tulisokibart in Moderately to Severely Active Ulcerative Colitis
404 Reached
Similar Content

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

SECCA for Managing Anal Incontinence
203 Reached2 Comments2 Likes

Single-incision Laparoscopy for Gastrostomy
408 Reached2 Comments1 Likes

Abnormal Biliary Imaging in Patient with history of Hypothyroidism
116 Reached1 Comments2 Likes

Psychological Manifestations Of IBS
662 Reached1 Comments1 Likes